Casi Pharmaceuticals Stock Forecast

Sell candidate since Aug 07, 2026 Loss -6.83%

The Casi Pharmaceuticals, Inc. stock price fell by -6.83% on the last day (Monday, 10th Aug 2026) from $0.129 to $0.120. During the last trading day the stock fluctuated 0% from a day low at $0.120 to a day high of $0.120. The price has fallen in 4 of the last 10 days and is down by -6.83% for this period. Volume has increased on the last day by 7 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 7 thousand shares were bought and sold for approximately $805.44 .

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.111 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.99% during the next 3 months and, with a 90% probability hold a price between $0.116 and $0.268 at the end of this 3-month period.

CASIF Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Casi Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.128 and $0.144. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -52.00%. Further fall is indicated until a new bottom pivot has been found. Casi Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Casi Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.110 and $0.105. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Casi Pharmaceuticals, Inc. finds support just below today's level at $0.110. If this is broken, then the next support from accumulated volume will be at $0.105 and $0.103.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0.0155%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CASIF) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Casi Pharmaceuticals, Inc. to open at $0.120, and during the day (based on 14 day Average True Range), to move between $0.114 and $0.126, which gives a possible trading interval of +/-$0.0121 (+/-10.62%) up or down from last closing price. If Casi Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 10.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.123 (2.50%) than the support at $0.110 (8.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Casi Pharmaceuticals, Inc. stock A Buy?

The Casi Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Casi Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.133 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.120 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk